Lincluden Management Ltd. Sells 14,426 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Lincluden Management Ltd. decreased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.3% in the second quarter, Holdings Channel.com reports. The fund owned 215,551 shares of the pharmacy operator’s stock after selling 14,426 shares during the period. Walgreens Boots Alliance comprises about 1.1% of Lincluden Management Ltd.’s holdings, making the stock its 22nd biggest position. Lincluden Management Ltd.’s holdings in Walgreens Boots Alliance were worth $11,340,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. abrdn plc raised its stake in Walgreens Boots Alliance by 2.6% during the second quarter. abrdn plc now owns 487,676 shares of the pharmacy operator’s stock valued at $25,659,000 after purchasing an additional 12,476 shares in the last quarter. Cullen Capital Management LLC raised its stake in Walgreens Boots Alliance by 5.6% during the second quarter. Cullen Capital Management LLC now owns 2,599,729 shares of the pharmacy operator’s stock valued at $136,772,000 after purchasing an additional 137,190 shares in the last quarter. Rockefeller Capital Management L.P. raised its stake in Walgreens Boots Alliance by 14.6% during the first quarter. Rockefeller Capital Management L.P. now owns 87,882 shares of the pharmacy operator’s stock valued at $4,824,000 after purchasing an additional 11,174 shares in the last quarter. Kingsview Wealth Management LLC raised its stake in Walgreens Boots Alliance by 201.7% during the first quarter. Kingsview Wealth Management LLC now owns 26,400 shares of the pharmacy operator’s stock valued at $1,445,000 after purchasing an additional 17,649 shares in the last quarter. Finally, CIBC Asset Management Inc raised its stake in Walgreens Boots Alliance by 5.1% during the first quarter. CIBC Asset Management Inc now owns 146,891 shares of the pharmacy operator’s stock valued at $8,064,000 after purchasing an additional 7,177 shares in the last quarter. Hedge funds and other institutional investors own 55.65% of the company’s stock.

A number of equities research analysts recently issued reports on the stock. Truist Securities decreased their price target on shares of Walgreens Boots Alliance from $58.00 to $52.00 and set a “hold” rating on the stock in a research note on Friday, July 2nd. Wolfe Research reissued a “hold” rating and issued a $57.00 target price on shares of Walgreens Boots Alliance in a research note on Friday, July 2nd. Barclays reduced their target price on shares of Walgreens Boots Alliance from $55.00 to $53.00 and set an “equal weight” rating on the stock in a research note on Tuesday, July 6th. TheStreet downgraded shares of Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research note on Friday, June 18th. Finally, Credit Suisse Group reaffirmed a “hold” rating and issued a $48.00 price target on shares of Walgreens Boots Alliance in a research note on Friday. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $50.83.

Shares of NASDAQ:WBA traded up $0.73 during trading on Monday, reaching $49.04. The stock had a trading volume of 41,846 shares, compared to its average volume of 5,756,088. Walgreens Boots Alliance, Inc. has a one year low of $33.36 and a one year high of $57.05. The company has a market capitalization of $42.42 billion, a P/E ratio of 18.30, a PEG ratio of 1.41 and a beta of 0.49. The company has a current ratio of 0.77, a quick ratio of 0.53 and a debt-to-equity ratio of 0.34. The firm’s 50-day simple moving average is $48.50 and its 200 day simple moving average is $51.30.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, June 30th. The pharmacy operator reported $1.38 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.21. Walgreens Boots Alliance had a net margin of 1.66% and a return on equity of 20.79%. The business had revenue of $34.03 billion for the quarter, compared to analysts’ expectations of $33.47 billion. During the same period last year, the business earned $0.71 EPS. The company’s revenue was up 12.1% compared to the same quarter last year. Equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 4.75 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 10th. Investors of record on Friday, August 20th were given a $0.477 dividend. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.47. This represents a $1.91 annualized dividend and a dividend yield of 3.89%. The ex-dividend date was Thursday, August 19th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 40.30%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.

Featured Article: Quick Ratio

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.